These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22424506)

  • 1. Options for prosthetic pulmonary valve replacement.
    Emani SM
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2012; 15(1):34-7. PubMed ID: 22424506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of tissue valves.
    Chikwe J; Filsoufi F
    Semin Thorac Cardiovasc Surg; 2011; 23(1):18-23. PubMed ID: 21807294
    [No Abstract]   [Full Text] [Related]  

  • 3. Choice of prosthetic heart valve in adults an update.
    Rahimtoola SH
    J Am Coll Cardiol; 2010 Jun; 55(22):2413-26. PubMed ID: 20510209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticalcification strategies to increase bioprosthetic valve durability.
    Thiene G; Valente M
    J Heart Valve Dis; 2011 Jan; 20(1):37-44. PubMed ID: 21404896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic valve replacement dilemma: mechanical or biological prosthesis?
    Cannata A; Russo CF; Taglieri C
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1101-2; author reply 1102. PubMed ID: 18954665
    [No Abstract]   [Full Text] [Related]  

  • 6. Transannular pulmonary enlargement and bioprostheses for carcinoid disease.
    Choong CK; Arrowsmith JE; Klein AA; Wells FC
    Asian Cardiovasc Thorac Ann; 2009 Oct; 17(5):510-2. PubMed ID: 19917795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of reoperation for mitral bioprosthesis dysfunction.
    Jaussaud N; Gariboldi V; Grisoli D; Berbis J; Kerbaul F; Riberi A; Collart F
    J Heart Valve Dis; 2012 Jan; 21(1):56-60. PubMed ID: 22474743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
    McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
    Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioprosthetic durability assessment: importance of complete data.
    Jamieson WR
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):596; author reply 596-7. PubMed ID: 21241868
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation after bioprosthetic aortic valve replacement.
    Nowell J; Jahangiri M
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1201-2; author reply 1202. PubMed ID: 20951265
    [No Abstract]   [Full Text] [Related]  

  • 12. The Ross procedure: state of the art 2011.
    Stelzer P
    Semin Thorac Cardiovasc Surg; 2011; 23(2):115-23. PubMed ID: 22041040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitroflow pericardial aortic bioprosthesis in patients younger than 60 years.
    Yankah CA
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):e83-4. PubMed ID: 20708752
    [No Abstract]   [Full Text] [Related]  

  • 14. Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot.
    Chen PC; Sager MS; Zurakowski D; Pigula FA; Baird CW; Mayer JE; Del Nido PJ; Emani SM
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):352-60. PubMed ID: 22153723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
    Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous implantation of the pulmonary and aortic valves: indications and limitations.
    Khambadkone S; Nordmeyer J; Bonhoeffer P
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):57-61. PubMed ID: 17255818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increasing use of mechanical pulmonary valve replacement over a 40-year period.
    Stulak JM; Dearani JA; Burkhart HM; Connolly HM; Warnes CA; Suri RM; Schaff HV
    Ann Thorac Surg; 2010 Dec; 90(6):2009-14; discussion 2014-5. PubMed ID: 21095354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When repair is not feasible: prosthesis selection in children and adults with congenital heart disease.
    Said SM; Burkhart HM
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2014; 17(1):22-9. PubMed ID: 24725713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-six-year durability of an Ionescu-Shiley standard profile pericardial aortic valve.
    Honda K; Okamura Y; Nishimura Y; Uchita S
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):315-6. PubMed ID: 19914926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of valve replacement in children.
    Schaff HV; Danielson GK
    Cardiovasc Clin; 1986; 16(2):427-36. PubMed ID: 3742534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.